I am actually thinking maybe Cellceutix can make l
Post# of 72446
Posted On: 11/21/2015 4:19:28 PM
I am actually thinking maybe Cellceutix can make lemonade out of the Mako/Rosen lemons.
Reporters love a good story line. What if someone put together a story about the new white collar criminal activity of stock price manipulation being facilitated by social media and SA type sites. That Sullivan letter would make one hell of an argument that the SEC needs to come down hard on these guys. Steal a car, you do jail time. These guys are stealing from thousands of people at the same time, they should go to jail.
Did you see this I posted on the other site?
"Perhaps the most notable aspect of the vouchers so far is the price they have been able to command. BioMarin's voucher, the first ever to be sold, was purchased for $67 million. Several months later, Gilead Sciences purchased Knight Therapeutics' voucher for $125 million. In May 2015, Sanofi purchased yet another voucher for a record-setting $245 million, and in August 2015, AbbVie shattered that record by paying $350 million for a voucher originally awarded to United Therapeutics"
http://www.raps.org/Regulatory-Focus/News/201...-Vouchers/
Reporters love a good story line. What if someone put together a story about the new white collar criminal activity of stock price manipulation being facilitated by social media and SA type sites. That Sullivan letter would make one hell of an argument that the SEC needs to come down hard on these guys. Steal a car, you do jail time. These guys are stealing from thousands of people at the same time, they should go to jail.
Did you see this I posted on the other site?
"Perhaps the most notable aspect of the vouchers so far is the price they have been able to command. BioMarin's voucher, the first ever to be sold, was purchased for $67 million. Several months later, Gilead Sciences purchased Knight Therapeutics' voucher for $125 million. In May 2015, Sanofi purchased yet another voucher for a record-setting $245 million, and in August 2015, AbbVie shattered that record by paying $350 million for a voucher originally awarded to United Therapeutics"
http://www.raps.org/Regulatory-Focus/News/201...-Vouchers/
(0)
(0)